360 related articles for article (PubMed ID: 17901245)
21. Nucleic acid sensing promotes inflammatory monocyte migration through biased coagulation factor VIIa signaling.
Zelaya H; Grunz K; Nguyen TS; Habibi A; Witzler C; Reyda S; Gonzalez-Menendez I; Quintanilla-Martinez L; Bosmann M; Weiler H; Ruf W
Blood; 2024 Mar; 143(10):845-857. PubMed ID: 38096370
[TBL] [Abstract][Full Text] [Related]
22. Tissue factor-factor VIIa complex triggers protease activated receptor 2-dependent growth factor release and migration in ovarian cancer.
Chanakira A; Westmark PR; Ong IM; Sheehan JP
Gynecol Oncol; 2017 Apr; 145(1):167-175. PubMed ID: 28148395
[TBL] [Abstract][Full Text] [Related]
23. Protease-activated receptor-2 is essential for factor VIIa and Xa-induced signaling, migration, and invasion of breast cancer cells.
Morris DR; Ding Y; Ricks TK; Gullapalli A; Wolfe BL; Trejo J
Cancer Res; 2006 Jan; 66(1):307-14. PubMed ID: 16397244
[TBL] [Abstract][Full Text] [Related]
24. Role of tissue factor in cancer.
Kasthuri RS; Taubman MB; Mackman N
J Clin Oncol; 2009 Oct; 27(29):4834-8. PubMed ID: 19738116
[TBL] [Abstract][Full Text] [Related]
25. Tissue factor-factor VIIa-specific up-regulation of IL-8 expression in MDA-MB-231 cells is mediated by PAR-2 and results in increased cell migration.
Hjortoe GM; Petersen LC; Albrektsen T; Sorensen BB; Norby PL; Mandal SK; Pendurthi UR; Rao LV
Blood; 2004 Apr; 103(8):3029-37. PubMed ID: 15070680
[TBL] [Abstract][Full Text] [Related]
26. Coagulation factor VIIa enhances programmed death-ligand 1 expression and its stability in breast cancer cells to promote breast cancer immune evasion.
Paul S; Das K; Ghosh A; Chatterjee A; Bhoumick A; Basu A; Sen P
J Thromb Haemost; 2023 Dec; 21(12):3522-3538. PubMed ID: 37579880
[TBL] [Abstract][Full Text] [Related]
27. Tissue factor signaling: a multi-faceted function in biological processes.
van den Hengel LG; Versteeg HH
Front Biosci (Schol Ed); 2011 Jun; 3(4):1500-10. PubMed ID: 21622285
[TBL] [Abstract][Full Text] [Related]
28. Emerging insights in tissue factor-dependent signaling events.
Versteeg HH; Ruf W
Semin Thromb Hemost; 2006 Feb; 32(1):24-32. PubMed ID: 16479459
[TBL] [Abstract][Full Text] [Related]
29. Apixaban Suppresses the Release of TF-Positive Microvesicles and Restrains Cancer Cell Proliferation through Directly Inhibiting TF-fVIIa Activity.
Featherby S; Madkhali Y; Maraveyas A; Ettelaie C
Thromb Haemost; 2019 Sep; 119(9):1419-1432. PubMed ID: 31266079
[TBL] [Abstract][Full Text] [Related]
30. Tissue factor enhances protease-activated receptor-2-mediated factor VIIa cell proliferative properties.
Fan L; Yotov WV; Zhu T; Esmailzadeh L; Joyal JS; Sennlaub F; Heveker N; Chemtob S; Rivard GE
J Thromb Haemost; 2005 May; 3(5):1056-63. PubMed ID: 15869604
[TBL] [Abstract][Full Text] [Related]
31. Tissue Factor-Factor VIIa complex induces cytokine expression in coronary artery smooth muscle cells.
Demetz G; Seitz I; Stein A; Steppich B; Groha P; Brandl R; Schömig A; Ott I
Atherosclerosis; 2010 Oct; 212(2):466-71. PubMed ID: 20708733
[TBL] [Abstract][Full Text] [Related]
32. Tissue factor trafficking in fibroblasts: involvement of protease-activated receptor-mediated cell signaling.
Mandal SK; Pendurthi UR; Rao LV
Blood; 2007 Jul; 110(1):161-70. PubMed ID: 17384202
[TBL] [Abstract][Full Text] [Related]
33. Mitochondrial reactive oxygen species: a common pathway for PAR1- and PAR2-mediated tissue factor induction in human endothelial cells.
Banfi C; Brioschi M; Barbieri SS; Eligini S; Barcella S; Tremoli E; Colli S; Mussoni L
J Thromb Haemost; 2009 Jan; 7(1):206-16. PubMed ID: 18983479
[TBL] [Abstract][Full Text] [Related]
34. Ligand-induced protease receptor translocation into caveolae: a mechanism for regulating cell surface proteolysis of the tissue factor-dependent coagulation pathway.
Sevinsky JR; Rao LV; Ruf W
J Cell Biol; 1996 Apr; 133(2):293-304. PubMed ID: 8609163
[TBL] [Abstract][Full Text] [Related]
35. The epidermal growth factor receptor (EGFR) and proline rich tyrosine kinase 2 (PYK2) are involved in tissue factor dependent factor VIIa signalling in HaCaT cells.
Wiiger MT; Prydz H
Thromb Haemost; 2004 Jul; 92(1):13-22. PubMed ID: 15213840
[TBL] [Abstract][Full Text] [Related]
36. Hypoxia triggers a proangiogenic pathway involving cancer cell microvesicles and PAR-2-mediated heparin-binding EGF signaling in endothelial cells.
Svensson KJ; Kucharzewska P; Christianson HC; Sköld S; Löfstedt T; Johansson MC; Mörgelin M; Bengzon J; Ruf W; Belting M
Proc Natl Acad Sci U S A; 2011 Aug; 108(32):13147-52. PubMed ID: 21788507
[TBL] [Abstract][Full Text] [Related]
37. An anti-tissue factor monoclonal antibody which inhibits TF.VIIa complex is a potent anticoagulant in plasma.
Ruf W; Edgington TS
Thromb Haemost; 1991 Nov; 66(5):529-33. PubMed ID: 1803616
[TBL] [Abstract][Full Text] [Related]
38. PAR2-SMAD3 in microvascular endothelial cells is indispensable for vascular stability via tissue factor signaling.
Arderiu G; Espinosa S; Peña E; Aledo R; Badimon L
J Mol Cell Biol; 2016 Jun; 8(3):255-70. PubMed ID: 26658897
[TBL] [Abstract][Full Text] [Related]
39. Microarray studies of factor VIIa-activated cancer cells.
Petersen LC
Thromb Res; 2008; 122 Suppl 1():S11-3. PubMed ID: 18691491
[TBL] [Abstract][Full Text] [Related]
40. Evidence for tissue factor phosphorylation and its correlation with protease-activated receptor expression and the prognosis of primary breast cancer.
Rydén L; Grabau D; Schaffner F; Jönsson PE; Ruf W; Belting M
Int J Cancer; 2010 May; 126(10):2330-40. PubMed ID: 19795460
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
